Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial

Gena C. Dunivan, Brent A. Parnell, Anna Marie Connolly, Mary L. Jannelli, Bethany Jablonski Horton, Elizabeth J. Geller

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.

Original languageEnglish (US)
Pages (from-to)433-438
Number of pages6
JournalInternational Urogynecology Journal
Volume22
Issue number4
DOIs
StatePublished - Jan 1 2011

Fingerprint

Suburethral Slings
Bupivacaine
Postoperative Pain
Randomized Controlled Trials
Injections
Pain
Control Groups
Visual Analog Scale
Anti-Inflammatory Agents
Pharmaceutical Preparations

Keywords

  • Bupivacaine
  • Midurethral sling
  • Postoperative pain

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Urology

Cite this

Dunivan, G. C., Parnell, B. A., Connolly, A. M., Jannelli, M. L., Horton, B. J., & Geller, E. J. (2011). Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial. International Urogynecology Journal, 22(4), 433-438. https://doi.org/10.1007/s00192-011-1362-y

Bupivacaine injection during midurethral sling and postoperative pain : A randomized controlled trial. / Dunivan, Gena C.; Parnell, Brent A.; Connolly, Anna Marie; Jannelli, Mary L.; Horton, Bethany Jablonski; Geller, Elizabeth J.

In: International Urogynecology Journal, Vol. 22, No. 4, 01.01.2011, p. 433-438.

Research output: Contribution to journalArticle

Dunivan, GC, Parnell, BA, Connolly, AM, Jannelli, ML, Horton, BJ & Geller, EJ 2011, 'Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial', International Urogynecology Journal, vol. 22, no. 4, pp. 433-438. https://doi.org/10.1007/s00192-011-1362-y
Dunivan, Gena C. ; Parnell, Brent A. ; Connolly, Anna Marie ; Jannelli, Mary L. ; Horton, Bethany Jablonski ; Geller, Elizabeth J. / Bupivacaine injection during midurethral sling and postoperative pain : A randomized controlled trial. In: International Urogynecology Journal. 2011 ; Vol. 22, No. 4. pp. 433-438.
@article{fab50bcea2f9417797b39efb9d18bca1,
title = "Bupivacaine injection during midurethral sling and postoperative pain: A randomized controlled trial",
abstract = "Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125{\%} bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125{\%} bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125{\%} bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.",
keywords = "Bupivacaine, Midurethral sling, Postoperative pain",
author = "Dunivan, {Gena C.} and Parnell, {Brent A.} and Connolly, {Anna Marie} and Jannelli, {Mary L.} and Horton, {Bethany Jablonski} and Geller, {Elizabeth J.}",
year = "2011",
month = "1",
day = "1",
doi = "10.1007/s00192-011-1362-y",
language = "English (US)",
volume = "22",
pages = "433--438",
journal = "International Urogynecology Journal and Pelvic Floor Dysfunction",
issn = "0937-3462",
publisher = "Springer London",
number = "4",

}

TY - JOUR

T1 - Bupivacaine injection during midurethral sling and postoperative pain

T2 - A randomized controlled trial

AU - Dunivan, Gena C.

AU - Parnell, Brent A.

AU - Connolly, Anna Marie

AU - Jannelli, Mary L.

AU - Horton, Bethany Jablonski

AU - Geller, Elizabeth J.

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.

AB - Introduction: and hypothesis The aim of this study was to investigate the impact of retropubic injection of 0.125% bupivacaine during midurethral sling placement on postoperative pain. Methods: A randomized, double-blind trial of 42 women undergoing midurethral sling for stress incontinence was conducted. The intervention group received an injection of 0.125% bupivacaine in the retropubic space prior to midurethral sling placement, while the control group received no injection. Pain scores were recorded via a 10-cm visual analog scale at 2, 6, and 24 h postoperatively. Results: Pain scores were lower in the bupivacaine group compared to the control group at 2 h (1.9 versus 2.6, p= 0.05). Mean pain scores were similar at all other time points (all p>0.45). Participants in both groups used similar amounts of pain medication in the hospital, except that patients in the bupivacaine group used more PO nonsteroidal anti-inflammatory drugs (p=0.047). Conclusions: Retropubic injection of 0.125% bupivacaine at the time of midurethral sling placement decreases shortterm postoperative pain.

KW - Bupivacaine

KW - Midurethral sling

KW - Postoperative pain

UR - http://www.scopus.com/inward/record.url?scp=79959782331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959782331&partnerID=8YFLogxK

U2 - 10.1007/s00192-011-1362-y

DO - 10.1007/s00192-011-1362-y

M3 - Article

C2 - 21318442

AN - SCOPUS:79959782331

VL - 22

SP - 433

EP - 438

JO - International Urogynecology Journal and Pelvic Floor Dysfunction

JF - International Urogynecology Journal and Pelvic Floor Dysfunction

SN - 0937-3462

IS - 4

ER -